Patient P-01671
Synthetic patientNBL-101 · Day 109 · 45–54 · M · baseline S04Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
24%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S04
- Day 46 SC-12 recommended — Supportive Compound SC-12
- Day 47 Patient accepted — Started SC-12 in the companion
- Day 53 GI symptom burden −17% vs expected — Supportive Compound SC-12
- Day 59 Tolerance state changed — Unstable → Improving
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+15
- Inflammatory activity+6
- Nutritional resilience-5
- Toxicity-4
- Treatment adherence+2
What helped?
- Supportive Compound SC-12Day 46Result: symptom burden −17%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion18.2/100
worsening · +1.0 vs previous 14 d
Toxicity
Blood4.3/100
worsening · +6.8 vs previous 14 d
Sleep quality
Wearable70.8/100
stable · +0.7 vs previous 14 d
Energy level
Daily log7.7/10
worsening · -0.4 vs previous 14 d
Stress level
Daily log4.2/10
worsening · +0.5 vs previous 14 d
Steps
Wearable7,987
worsening · -483 vs previous 14 d
Adherence
Companion99.1 %
improving · +6.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 94 from the failing basin, 12 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load-1.5no signal · 42%
- Spicy / capsaicin+0.9no signal · 22%
- Insoluble fibre-0.4no signal · 15%
- Dietary fat load-0.2no signal · 15%
- Alcohol+0.1no signal · 15%
- Simple carbohydrates0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
Microbiome
Shannon diversity 4.4 · butyrate capacity 49/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 55 ms
- Sleep
- 8.0 h
- Steps
- 8,109
- Resting HR
- 55 bpm
Daily log: GI score 18, nutritional resilience 70, adherence 99.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.